FRR Shares (Makes you Realise)

Equity

Home/ Are You A Trader/ Market Info/ Company Profile/ Smart Quotes

COMPANY PROFILE

TTK HEALTHCARE LTD.

NSE : TTKHLTCAREBSE : 507747ISIN CODE : INE910C01018Industry : Pharmaceuticals & DrugsHouse : TTK

BSE1285.8524.05 (+1.91 %)

PREV CLOSE (Rs.) 1261.80

OPEN PRICE (Rs.) 1261.80

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 1305

TODAY'S LOW / HIGH (Rs.)1255.25 1330.00

52 WK LOW / HIGH (Rs.)991 1923

NSE1286.1026.8 (+2.13 %)

PREV CLOSE( Rs. ) 1259.30

OPEN PRICE (Rs.) 1261.30

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 1286.10 (100)

VOLUME 34080

TODAY'S LOW / HIGH(Rs.) 1240.00 1324.70

52 WK LOW / HIGH (Rs.)1101.05 1893.95

More From Company Profile

Smart Quotes

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Trade Value (Rs. in Lacs)

16.74

Dividend Yield(%)

0.78

TTM EPS (Rs.)

57.79

P/E Ratio

22.25

Book Value (Rs.)

743.86

Face Value (Rs.)

MCap (Rs. in Mn)

18169.49

Price/Earning (TTM)

20.19

Price/Sales (TTM)

2.27

Price/Book (MRQ)

1.73

PAT Margin (%)

7.94

ROCE (%)

8.72

Incorporation Year : 1958

Management Info :

T T Raghunathan - Chairman - Managing Director

Registered Office :

Address : No 6 , Cathedral Road, , ,
Chennai,
Tamil Nadu-600086

Phone : 044-28116106-08

Email : info@ttkhealthcare.com

Website : www.ttkhealthcare.com

Registrars Details :

Data Software Research Co Pvt Ltd

19 Pycroft Garden Road,Off Haddows Road,Nungambakkam,Chennai

Listing : BSE, NSE

NEWS

28Apr TTK Healthcare informs about outcome o
With reference to communication No.TTKH:SEC:SL:097:25 dated March 27, 20..

04Apr TTK Healthcare informs about complianc
TTK Healthcare has informed that it enclosed a copy of the Certificate d..

16Jul Ttk Healthcare informs about loss of s
Ttk Healthcare has informed that Ketan Narendra Desai (Claimant), the le..

Financials

	QTR Mar 25	ANNUAL 25
Net Profit	161.47	816.57
Gross Profit	217.55	1083.32
Operating Profit	306.91	1060.83
Net Sales	1903.6	8014.93

Rs. in Millions

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Emcure Pharma (BSE)

1288.65 (10.00%)

M.Cap (Rs. in Cr)24417.77

Medplus Health Servi (BSE)

950.90 (7.36%)

M.Cap (Rs. in Cr)11381.69

Shilpa Medicare (BSE)

781.50 (6.33%)

M.Cap (Rs. in Cr)7642.36

Orchid Pharma (BSE)

754.40 (4.21%)

M.Cap (Rs. in Cr)3826.25

Shareholding Pattern

	PROMOTERS	74.56%
	NON-INSTITUTION	22.4%
	FII	1.9%
	FI/BANKS/INSURANCE	0.01%
	MUTUAL FUNDS/UTI	0%
	GOVERNMENT	0%

Mf Holding

Scheme Name

Hold(%)

No Data Found

Attention Investors

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month, Issued in the interest of Investors.

Risk Disclosure on Derivatives | Smart ODR | Mandatory Display | KYC Validation Links

BSE / NSE SEBI Registration No. INZ000279232, Depository Participant SEBI Registration No. – IN DP CDSL 132-2015

Mutual funds - ARN No. 81648 , Investment Adviser SEBI Registration No. : INA000008668.

close X

Download Client Registration Documents

Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do's & Don't's) in Vernacular Language :

Assamese Bengali Gujarati Hindi Kanada

Kashmiri Konkani Malyalam Marathi Oriya

Punjabi Sindhi Tamil Telegu Urdu

NOTE : " This document is a translated version of the client registration documents in English and is being provided in vernacular language to facilitate better understanding by the investors. In case of any ambiguity, the contents of the English version would prevail. "

CLOSE X

Risk Disclosures On Derivatives

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22